Management of Epigastric Pain and Nausea in SLE Patients

First-Line Management Approach

The American College of Rheumatology recommends maintaining hydroxychloroquine in all SLE patients with gastrointestinal symptoms as it forms the basis of SLE treatment and helps control disease activity 1

For patients with inadequate response to PPIs, the American College of Radiology suggests considering adding anti-emetics (e.g., ondansetron, metoclopramide) for persistent nausea 2
The American College of Radiology also recommends considering antacids or H2 blockers as adjunctive therapy 2
For pain management, the American College of Rheumatology may use NSAIDs judiciously for short periods in patients at low risk for complications 3

The European League Against Rheumatism recommends glucocorticoids as the mainstay of treatment for acute flares affecting the gastrointestinal tract 4
For severe presentations, the European League Against Rheumatism suggests considering pulse intravenous methylprednisolone (250-1000 mg daily for 1-3 days) 5

The European Society for Clinical Nutrition and Metabolism recommends dietary modifications, including small, frequent meals rather than large meals, low-fat diet if fat malabsorption is suspected, and avoidance of known trigger foods (spicy, acidic, caffeine) 6

The American College of Rheumatology recommends monitoring for medication interactions, particularly with hydroxychloroquine and immunosuppressants 1
The American College of Radiology suggests regular screening for H. pylori infection in patients with persistent symptoms despite therapy 2
The American College of Radiology also recommends considering endoscopy for patients with alarm symptoms (weight loss, bleeding, persistent vomiting) or suboptimal response to therapy 2